following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
.
schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals."
.
marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
.
``much of this delay in implementation can be attributed to the lack of coordination and cooperation between the city and county.''
. my profile
.
april 2008 (21)
. would identify hospitals that are best positioned to treat strokes and establish protocols for emergency responders handling stroke patients.